Pursuit Vascular, Inc., manufacturer of ClearGuard HD Antimicrobial Caps, the leading antimicrobial device for catheter-based dialysis patients, announces that the U.S. Food and Drug Administration […]
The two Spectro products are inductively coupled plasma optical emission spectrometry (ICP-OES) and energy dispersive X-ray fluorescence (XRF) technologies have seen dramatic improvements in recent […]
Arch Biopartners, Inc., a portfolio-based biotechnology company, announces it has joined forces with Nucro-Technics in Scarborough, Ontario to complete the preclinical toxicology and pharmacology studies […]
Delivra Corp. announces that its R&D, pre-clinical and clinical teams have successfully developed and tested line-extension products using its precision topical delivery system platform, DelivraTM.
The Ontario Bioscience Innovation Organization (OBIO) announces its 2018 Capital Access Advisory Program (CAAP) and the 12 high-potential health science companies in this year’s cohort. Now in its […]